Back to News
Market Impact: 0.2
SpyGlass Pharma Acquires Advanced Vision Science For $13 Mln In Cash
Source: Nasdaq
M&A & RestructuringHealthcare & BiotechMedical Technology
SpyGlass Pharma acquired all outstanding common shares of ophthalmic medical-device company Advanced Vision Science for approximately $13 million in cash. The transaction expands SpyGlass Pharma's presence in ophthalmic devices, though the modest deal size suggests limited broader market impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
SGP0.40
More News
- $8.2B acquisition validates AI-picked chip stock: +20% since June
- Nuveen CEO on Schroders Deal, Plans for Combined Company
- Paramount promised 30 movies a year to win Warner Bros. Losing Miramax if it fails may not scare it
- One of our most recent defensive buys cleared a hurdle and its stock jumped
- Bargain Britain lures foreign buyers as hostile takeovers surge
- Onsemi revises Synaptics deal to $123/sh all-cash, shares of both soar